Walleye Capital LLC Oramed Pharmaceuticals Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.93 - $13.1 $69,676 - $472,936	36,102 New	36,102 $78,000
Q3 2022 Nov 14, 2022	BUY	$4.6 - $9.91 $360,722 - $777,122	78,418 New	78,418 $508,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $300,900 - $510,318	-36,740 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$12.98 - $29.75 $476,885 - $1.09 Million	36,740 New	36,740 $524,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $100M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.